Fulgent Genetics, Inc. (FLGT) Stock Analysis

Free AI-powered analysis and research for Fulgent Genetics, Inc. stock

Sector: Healthcare

Analyze Fulgent Genetics, Inc. (FLGT) Stock

Fulgent Genetics, Inc. (FLGT) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into FLGT stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Fulgent Genetics, Inc. stock.

📰 Latest Update

Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx

Tue, March 17, 2026 at 8:31 PM UTC 4 min read

Fulgent Genetics (FLGT) has successfully completed its acquisition of Bako Diagnostics and StrataDx, expanding its portfolio in the diagnostics sector. This strategic move is expected to enhance FLGT's capabilities in providing advanced diagnostic solutions, potentially driving revenue growth and market share. For investors, this acquisition signifies Fulgent's commitment to innovation and diversification, positioning the company for future success in a competitive industry.

Read full article →

Why Analyze Fulgent Genetics, Inc. (FLGT) with StockIQ?

• ✅ Free AI-powered analysis of Fulgent Genetics, Inc. (FLGT) stock
• ✅ Real-time technical indicators for Fulgent Genetics, Inc. stock
• ✅ Comprehensive risk assessment for FLGT
• ✅ No credit card required

People also watch